A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus

被引：98

作者：

Orru, Valeria ^{[1
]}

Tsai, Sophia J.

Rueda, Blanca ^{[2
]}

Fiorillo, Edoardo ^{[1
]}

Stanford, Stephanie M. ^{[1
]}

Dasgupta, Jhimli

Hartiala, Jaana ^{[1
,3
]}

Zhao, Lei ^{[1
]}

Ortego-Centeno, Norberto ^{[4
]}

D'Alfonso, Sandra ^{[5
,6
]}

Arnett, Frank C. ^{[7
]}

Wu, Hui ^{[8
]}

Gonzalez-Gay, Miguel A. ^{[9
]}

Tsao, Betty P. ^{[8
]}

Pons-Estel, Bernardo ^{[10
]}

Alarcon-Riquelme, Marta E. ^{[11
]}

He, Yantao ^{[12
]}

Zhang, Zhong-Yin ^{[12
]}

Allayee, Hooman ^{[1
,3
]}

Chen, Xiaojiang S.

Martin, Javier ^{[2
]}

Bottini, Nunzio ^{[1
]}

机构：

[1] Univ So Calif, Inst Med Genet, Keck Sch Med, Los Angeles, CA 90033 USA

[2] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain

[3] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA

[4] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain

[5] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy

[6] Univ Piemonte Orientale, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy

[7] Univ Texas Houston, Sch Med, Dept Rheumatol, Houston, TX USA

[8] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[9] Hosp Xeral Calde, Rheumatol Unit, Lugo, Spain

[10] Sanatorio Parque, Rosario, Santa Fe, Argentina

[11] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden

[12] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA

来源：

HUMAN MOLECULAR GENETICS | 2009年 / 18卷 / 03期

基金：

新加坡国家研究基金会;

关键词：

LYMPHOID TYROSINE PHOSPHATASE; CELL ANTIGEN RECEPTOR; GENETIC-VARIATION; POLYMORPHISM; IDENTIFICATION; ANTIBODIES; TOLERANCE; HAPLOTYPE; KINASE;

D O I：

10.1093/hmg/ddn363

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A gain-of-function R620W polymorphism in the PTPN22 gene, encoding the lymphoid tyrosine phosphatase LYP, has recently emerged as an important risk factor for human autoimmunity. Here we report that another missense substitution (R263Q) within the catalytic domain of LYP leads to reduced phosphatase activity. High-resolution structural analysis revealed the molecular basis for this loss of function. Furthermore, the Q263 variant conferred protection against human systemic lupus erythematosus, reinforcing the proposal that inhibition of LYP activity could be beneficial in human autoimmunity.

引用

页码：569 / 579

页数：11

共 50 条

[1] PTPN22 Gene Polymorphisms in Pediatric Systemic Lupus Erythematosus
Bahrami, Tayyeb
Valilou, Saeed Farajzadeh
Sadr, Maryam
Soltani, Samaneh
Salmaninejad, Arash
Soltaninejad, Ehsan
Yekaninejad, Mir Saeed
Ziaee, Vahid
Rezaei, Nima
FETAL AND PEDIATRIC PATHOLOGY, 2020, 39 (01) : 13 - 20
[2] A "reduced function" PTPN22 variant modulates the Toll-like receptor-driven type 1 interferon response in systemic lupus erythematosus
Wang, Yaya
Yamamoto, Ami
Gillespie, Emily
Fazeli, Parastoo
Peterson, Erik
JOURNAL OF IMMUNOLOGY, 2014, 192
[3] PTPN22 Silencing in the NOD Model Indicates the Type 1 Diabetes-Associated Allele Is Not a Loss-of-Function Variant
Zheng, Peilin
Kissler, Stephan
DIABETES, 2013, 62 (03) : 896 - 904
[4] PTPN22 C1858T VARIANT IS A RISK FACTOR FOR SYSTEMIC LUPUS ERYTHEMATOSUS BUT NOT FOR RHEUMATOID ARTHRITIS IN THE ALGERIAN POPULATION
Salah, S. S.
Fodil, D.
Iguerguezdaoune, H.
Amroun, H.
Benidir, M.
Djennane, M.
Mebarek, A. Moussa
Hakem, D.
Acheli, D.
Mechid, F.
Makhloufi-Dahou, C.
Djoudi, H.
Abbadi, M. C.
Tamouza, R.
Lefkir-Tafiani, S.
Attal, N.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 898 - 898
[5] The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population
Ramirez, M.
Quintana, G.
Diaz-Gallo, L. -M.
Caminos, J.
Garces, M.
Cepeda, L.
Rondon, F.
Restrepo, J. F.
Egea, E.
Garavito, G.
Robledo, G.
Martin, J.
Iglesias-Gamarra, A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 520 - 524
[6] PTPN22 inhibition prevents the production of autoreactive B cells in systemic lupus erythematosus
Mirousea, A.
Kalayci, F. Naz Cemre
Maienschein-Cline, M.
Le Guen, Y.
Sefik, E.
Delmotte, F. R.
Chen, J. W.
Barnas, J.
Clark, M.
Flavell, R. A.
Anolik, J. H.
Meffre, E.
REVUE DE MEDECINE INTERNE, 2023, 44 : A319 - A320
[7] PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus
Wang, Yaya
Ewart, David
Crabtree, Juliet N.
Yamamoto, Ami
Baechler, Emily C.
Fazeli, Parastoo
Peterson, Erik J.
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (09) : 2403 - 2414
[8] Tumor necrosis factor receptor II and PTPN22 genes polymorphisms and the risk of systemic lupus erythematosus in Egyptian children
Eid, Riham
Hammad, Ayman
Abdelsalam, Maha
Fathy, Aya Ahmed
Abd-El Ghafaar, Dena M.
Elmarghany, Eman B.
El-Hanafy, Aya A.
Mostafa, Nora
Niazey, Nermeen A.
Korkor, Mai S.
Hamdy, Nashwa
LUPUS, 2021, 30 (09) : 1449 - 1458
[9] Familial systemic lupus erythematosus associated with a loss-of-function mutation in TRPC6
Chen, Dandan
Yin, Hanlin
Zhang, Le
Li, Fubin
Lu, Liangjing
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (08) : 1120 - 1122
[10] A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models
Dai, Xuezhi
James, Richard G.
Habib, Tania
Singh, Swati
Jackson, Shaun
Khim, Socheath
Moon, Randall T.
Liggitt, Denny
Wolf-Yadlin, Alejandro
Buckner, Jane H.
Rawlings, David J.
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (05): : 2024 - 2036

← 1 2 3 4 5 →